Luminex Acquires GenturaDX, Inc.; Wins M&A Deal of the Year

The firm assisted Luminex Corporation in its acquisition of Gentura DX, Inc., a BVI Corporation. The acquisition was valued at $50 million. The firm received an “M&A Deal of the Year” award as part of the 11th Annual M&A Advisor Awards for our work on behalf of Luminex Corporation in connection with this transaction. The Luminex transaction also was named a finalist for “Sector Deal of the Year” in the “Healthcare / Life Sciences (between $10 million and $100 million)” category.

Luminex Corporation (NASDAQ: LMNX) develops, manufactures and markets proprietary biological testing technologies, with applications throughout the life-sciences industry.

You Also May Be Interested In:

  • Representation of Twin River Worldwide Holdings, Inc. (NYSE: TRWH) in its definitive agreement to acquire Jumer’s Casino & Hotel, from Delaware North Companies Gaming & Entertainment, Inc., for $120 million in cash

     

    We represented Twin River Worldwide Holdings, Inc. in its definitive agreement to acquire Jumer's Casino & Hotel, from Delaware North...
    Client Type: Public Company
  • Representation of Southern Ear, Nose, and Throat and Allergy (SENTA) Partners, an ENT and allergy management services organization backed by Shore Capital Partners, in its affiliation with Atlanta Allergy & Asthma, the largest allergy practice in Georgia

    We represented Southern Ear, Nose, and Throat and Allergy (SENTA) Partners, an ENT and allergy management services organization backed by...
    Client Type: Private Company
  • Representation of Truxton Trust, a subsidiary of financial holding company, Truxton Corporation (OTCPK: TRUX), in the sale of $15 million aggregate principal amount of fixed-to-floating rate subordinated notes due in 2030

    We represented Truxton Trust in the sale of $15 million aggregate principal amount of fixed-to-floating rate subordinated notes due in...
    Client Type: Public Company